Novabay Pharmaceuticals Announces Preliminary Net Revenue For The Second Quarter Of 2024 Of $2.4M Versus Consensus Of $3.15M And For The First Half Of 2024 Of $5M, Primarily Derived From The Company's Eyecare Products
Novabay Pharmaceuticals Announces Preliminary Net Revenue For The Second Quarter Of 2024 Of $2.4M Versus Consensus Of $3.15M And For The First Half Of 2024 Of $5M, Primarily Derived From The Company's Eyecare Products
Novabay Pharmaceuticals宣佈2024年第二季度初步淨營業收入爲240萬美元，低於市場預期的315萬美元，並且2024年上半年營業收入爲500萬美元，主要來自公司的眼科產品。
Net revenue from the Company's eyecare products increased by 9% for both the second quarter and the first half of 2024 over the corresponding periods in 2023. NovaBay also expects 2024 net revenue from the Company's eyecare products to be approximately $10 million.
該公司眼科產品的淨營業收入在2024年第二季度和上半年相比於2023年同期增長了9%。NovaBay還預計2024年該公司眼科產品的淨營業收入約爲1000萬美元。
資訊熱榜
更新時間